Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Blood Biomarker Predicts Cardiovascular Disease

By LabMedica International staff writers
Posted on 07 Jun 2010
A simple blood test helps to identify vascular inflammation in patients at risk of heart disease. More...


An enzyme found in blood that binds predominately to low-density lipoprotein (LDL) was implicated as a risk factor for coronary artery disease. Increased activity of lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet-activating factor acetylhydrolase (PAF-AH), is often associated with atherosclerosis. It is considered key to the progression and rupture of fatty plaques that can block coronary arteries and lead to heart attacks.

The activity and mass of LpPLA2 was measured in high-risk patients undergoing arteriography (angiography), a medical imaging technique that visualizes the lumen of blood vessels and heart chambers. There were 336 Caucasians and 224 African-Americans participants in the study.

The results of the study showed that LpPLA2 activity was increased in both Caucasians and Afro-Americans, who had coronary heart disease, but only in the latter group was the LpPLA2 index found to be independently predictive of coronary artery disease.

"Arteriography is highly effective, but considered too risky and expensive for general screening," said Lars Berglund MD PhD, the lead scientist at the University of California, (UC Davis; Sacramento, CA, USA). Therefore, a simple blood test that could reliably predict the risk of a heart attack would be preferable to the invasive procedure. The test for LpPLA2 is widely available and further studies of this enzyme and other inflammatory components on a wider population will enable scientists to diagnose and predict heart disease in different ethnic and racial groups.

The study was published in 2010 in the Journal of Clinical Endocrinology and Metabolism. The information provided in this study will enable physicians to tailor the therapy to the patient's specific needs.

Related Links:
University of Davis



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.